Day One Biopharmaceuticals Overview

Day One Biopharmaceuticals Gross Profit

Gross Profit analysis for DAWN.

Quarterly Gross Profit

$47.64M

↑ 81.64% YoY

As of Dec 31, 2025

Annual Gross Profit (TTM)

$140.97M

↑ 170.71% YoY

Trailing 12 months ending Dec 31, 2025

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin